There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Aidan's Law

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Public Health Service Act, in relation to requiring adrenoleukodystrophy screening of newborns.

Actions Overview (1)

Date Actions Overview
03/03/2016Introduced in Senate

All Actions (1)

Date All Actions
03/03/2016Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Action By: Senate

Cosponsors (4)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Bennet, Michael F. [D-CO] 05/18/2016
Sen. Mikulski, Barbara A. [D-MD] 05/18/2016
Sen. Gillibrand, Kirsten E. [D-NY] 05/26/2016
Sen. Blumenthal, Richard [D-CT] 06/28/2016

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Health, Education, Labor, and Pensions03/03/2016 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (7)

Latest Summary (1)

There is one summary for S.2641. View summaries

Shown Here:
Introduced in Senate (03/03/2016)

Aidan's Law

This bill amends the Public Health Service Act to require hospitals, child care centers, clinics, and similar institutions caring for infants who are 28 days or less of age to administer to such infants a test for adrenoleukodystrophy, a progressive genetic disease that can cause behavioral changes, seizures, and other neurological symptoms.

To be eligible for funds under the Heritable Disorders Program, a state must establish adrenoleukodystrophy testing standards and procedures. These standards and procedures are subject to review and approval by the Advisory Committee on Heritable Disorders in Newborns and Children. The committee must establish standards and procedures for states without approved standards and procedures.